ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹16 Cr | ₹12 Cr | ₹14 Cr | ₹26 Cr | ₹27 Cr |
What is the latest Total Non-Current Liabilities ratio of ALBERT DAVID ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹16 Cr |
Mar2023 | ₹12 Cr |
Mar2022 | ₹14 Cr |
Mar2021 | ₹26 Cr |
Mar2020 | ₹27 Cr |
How is Total Non-Current Liabilities of ALBERT DAVID Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹16 Cr | 34.17 | |
Mar2023 | ₹12 Cr | -17.53 | |
Mar2022 | ₹14 Cr | -43.56 | |
Mar2021 | ₹26 Cr | -4.59 | |
Mar2020 | ₹27 Cr | - |
Compare Total Non-Current Liabilities of peers of ALBERT DAVID
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALBERT DAVID | ₹656.1 Cr | -7% | -13.1% | -25.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,692.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,215.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹115,000.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,616.4 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,841.4 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
ALBERT DAVID Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALBERT DAVID | -7% |
-13.1% |
-25.5% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses